Togetherall Secures $10 Million Investment from FPE Capital - 09 November 2020 11:01

LONDON, Nov. 9, 2020/PRNewswire-AsiaNet/-- Established mental health platform, Togetherall, secures $10 million investment Investment from growth investor FPE Capital follows Togetherall's accelerated expansion in UK and North America Togetherall provides a safe, clinically managed...

  Initiation of a "First in Human" Clinical Trial for an Innovat... - 09 November 2020 11:00

TOULOUSE, France, Nov. 9, 2020 /PRNewswire-AsiaNet/-- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pier...

  Large Study Shows That A Simple Blood Test Can Accurately Diff... - 09 November 2020 07:00

LONDON, Nov. 9, 2020, /PRNewswire-AsiaNet/-- A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous gr...

  Semaglutide 2.4 mg injection demonstrated significant weight l... - 06 November 2020 02:43

BAGSVÆRD, Denmark, Nov. 5, 2020 /PRNewswire-AsiaNet / -- Results of a phase 3a trial showed that investigational drug semaglutide 2.4 mg once-weekly subcutaneous as an adjunct to intensive behavioural therapy (IBT) demonstrated significantly more body weight loss compared to placebo plus IBT.[i] The STE...

  WuXi Biologics adopt Purolite Life Sciences Protein A resin fo... - 05 November 2020 10:57

CARDIFF, South Wales, Nov. 5, 2020 /PRNewswire-AsiaNet/ -- Purolite Ltd., a global manufacturer of resin-based separation, purification and extraction technologies, today announces that it will supply its Protein A capture resin, Praesto(R) Jetted A50 to WuXi Biologics for immediate use. WuXi Biologic...

  Healthscope selects Adoreboard to improve Patient Experience i... - 05 November 2020 09:00

BELFAST, Ireland, Nov. 5, 2020 /PRNewswire-AsiaNet/ -- AI is being used to understand patients' emotions to help detect breaches in COVID-19 across 43 Healthscope hospitals in Australia with the deployment of Emotion AI technology Adoreboard. As hospitals wrestle with the challenge of COVID-19, Hea...

  New report from the Global State of Tobacco Harm Reduction rev... - 04 November 2020 17:00

LONDON, Nov. 4, 2020 /PRNewswire-AsiaNet/ -- Burning Issues: The Global State of Tobacco Harm Reduction (GSTHR) 2020 [ https://gsthr.org/resources/item/burning-issues-global-state-tobacco-harm-reduction-2020] published by UK public health agency Knowledge Action Change (KAC) [https://kachang...

  Dazhou, China: No Family or Person Left behind on Way out of P... - 03 November 2020 18:42

CHENGDU, China, Nov. 3, 2020 /Xinhua-AsiaNet/-- A task team of the Dazhou Disabled Persons' Federation (DDPF), together with multiple medical rehabilitation institutions, spent their time from Oct. 19 to 21, in Wanyuan, Dazhou, providing the locals with disabilities (PWDs) with "Express Medical...

  RevImmune advances new immunotherapy in COVID-19 - 03 November 2020 00:00

BETHESDA, Maryland, Nov. 3, 2020 /PRNewswire-AsiaNet/ -- RevImmune, a privately held biotech company based in Paris, France and Bethesda, MD, developing CYT107 (recombinant human Interleukin-7) for infectious diseases, sepsis and cancer, announced today that its "ILIAD-7" international randomized contro...

  Investments aim to strengthen capabilities of DuPont(TM) Liveo... - 02 November 2020 12:00

WILMINGTON, Del., Nov. 2, 2020 /PRNewswire-AsiaNet/ -- DuPont™ (NYSE: DD), a globally recognized leader in silicone-based technology and innovations for healthcare, is making significant investments in both capital and resources to strengthen strategic capabilities of its Liveo™ brand healthcare silic...